You can find here all the latest news of NBD, whether participation in conferences, new collaborations, patents, research and development, recruitments etc…

Nostrum Biodiscovery sponsors ISQBP meeting

June 2018

The ISQBP President’s meeting is held every two years acting as a gathering point point for the community working on molecular simulations of biomolecular systems.

Nostrum Biodiscovery attends the BIO Convention at Boston

June 2018

The Bio convention is one of the greatest events of the year to catch up with customers, investors and partners.


December 2017

Here we go... the video of the chess tournament which took place on DEC 20th. Hope you'd enjoy it and congrats to the champ!

NBD I Nostrum Biodiscovery appoints Emilio Díez as Strategic Consultant

November 2017

NBD has appointed Dr. Emilio Díez, former GSK VP as new member of the Strategic Advisory Board.

NBD I Nostrum Biodiscovery at the SBDD Conference

September 2017

NBD has attended the SBDD conference in Lausanne which aims to discuss about computational methods as effective tools for drug discovery.

ASTRAZENECA accelerates PAR2 drug discovery using PELE

May 2017

AstraZeneca in collaboration with Heptares Therapeutic, has made significant progress with the new target called PAR2.

Successful NBD I Nostrum Biodiscovery meeting in San Diego!

July 2017

NBD is running up its drug discovery programmes due to the extraordinary contacts at the BIO 2017.

NBD I Nostrum Biodiscovery at the ACCIO Investment Forum

June 2017

TBD has been selected as one of the seven most innovative companies among +100 SMEs.

NBD I Nostrum Biodiscovery Joins Barcelona Bioinformatics (BIB)

May 2017

NBD joins Barcelona Bioinformatics (BIB), established to meet synergies between biology and computer science.